Observing complications and responses in cancer patients treated with anti-VEGF therapies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data on complications and clinical responses in cancer patients undergoing treatment with anti-VEGF-related therapies at Emory University and the University of Texas M.D. Anderson Cancer Center. The primary objective is to explore the incidence of clinical complications associated with these therapies. Secondary objectives include examining the correlation between clinical response rates and a novel blood pressure scoring system, as well as the relationship between toxicity grades and treatment responses. Patient medical records will be reviewed to gather relevant information.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients must be able to understand and be willing to sign a written informed consent document
* Patients must be receiving any anti-VEGF-related regimen in monotherapy or combination therapy

Where it's running

• M D Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Nicolas L Palaskas — M.D. Anderson Cancer Center

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Video education to boost knowledge and interest in cancer clinical trials

  Adults in the Detroit area will watch a short educational video to see if it increases their knowledge about and interest in cancer clinical trials.

  Recruiting Barbara Ann Karmanos Cancer Institute · Detroit, Michigan · NCT06501040

• Using alteplase to improve fluid drainage and breathlessness in patients with malignant pleural effusion

  This study tests if the medication alteplase can help people with fluid buildup in the lungs feel better and breathe easier when regular drainage isn’t enough.

  Recruiting Early Phase 1 M.D. Anderson Cancer Center · Baltimore, Maryland and 1 other locations · NCT06184321

• Using weighted blankets to reduce anxiety in cancer patients during infusions

  This study is testing whether using weighted blankets can help reduce anxiety in cancer patients during their first infusion therapy.

  Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT06089408

• Letermovir to prevent cytomegalovirus after pediatric stem cell transplant

  This study will try giving letermovir to CMV-positive children and adolescents receiving allogeneic stem cell transplants to see if it lowers CMV infections after transplant compared with the expected rate without prophylaxis.

  Recruiting at 32 sites Phase 3 Children's Oncology Group · Birmingham, Alabama and 32 other locations · NCT05711667

• Collecting blood and tissue samples for HIV/AIDS-related cancer research

  This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.

  Recruiting at 8 sites AIDS Malignancy Consortium · La Jolla, California and 7 other locations · NCT05663502

• Collecting blood samples to evaluate tests for early cancer detection

  This study is collecting blood and tissue samples from people with and without cancer to see if new tests can help detect cancer earlier.

  Recruiting at 619 sites Alliance for Clinical Trials in Oncology · Anchorage, Alaska and 750 other locations · NCT05334069

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.